Other Definitions
methotrexate (dict)

Methotrexate

bgcolor="#ffffff" align="center" colspan="2" |
align="center" colspan="2" | N-[4-[[(2,4-diamino-6-pteridinyl)methyl]
methylamino]benzoyl]-L-glutamic acid
CAS number
59-05-2
ATC code
L01BA01 & L04AX03
bgcolor="#eeeeee" | Chemical formula bgcolor="#ddeeff" | C20H22N8O5
bgcolor="#eeeeee" | Molecular weight bgcolor="#ddeeff" | 454.4
bgcolor="#eeeeee" | Bioavailability bgcolor="#ddeeff" | variable
bgcolor="#eeeeee" | Metabolism bgcolor="#ddeeff" | hepatic
bgcolor="#eeeeee" | Elimination half-life bgcolor="#ddeeff" | 3-15 hours
(dose dependent)
bgcolor="#eeeeee" | Excretion bgcolor="#ddeeff" | renal
bgcolor="#eeeeee" | Pregnancy category bgcolor="#ddeeff" | X
bgcolor="#eeeeee" | Legal status bgcolor="#ddeeff" | Schedule 4 (Aust)
PoM (UK)
bgcolor="#eeeeee" | Delivery bgcolor="#ddeeff" | oral, IM, IV, intrathecal
Methotrexate (abbreviated MTX; formerly known as amethopterin) is an antimetabolite drug used in treatment of cancer and autoimmune disease. It acts by inhibiting the metabolism of folic acid.

Uses

Methotrexate was originally used, as part of combination chemotherapy regimens, to treat many kinds of cancers. It is still the mainstay for the treatment of many neoplastic disorders including acute lymphoblastic leukemia. More recently it has come into use as a treatment for some autoimmune diseases, including psoriasis, rheumatoid arthritis, and crohn's disease. In the case of rheumatoid arthritis, parallel use with infliximab or etanercept has been shown to markedly improve symptoms. Although not licensed for this indication, methotrexate is also sometimes used (generally in combination with misoprostol) to terminate early pregnancies, particularly ectopic pregnancies. It can be taken orally or administered by injection (intramuscular, intravenous or intrathecal). Although daily preparations are occasionally used, most patients take weekly doses, which decreases the risk of certain side-effects.

Adverse effects

Possible side effects can include anemia, neutropenia, increased risk of bruising, and nausea. A small percentage of patients develop hepatitis, while there is an increased risk of pulmonary fibrosis. The higher doses of methotrexate often used in cancer chemotherapy can cause toxic effects to the rapidly-dividing cells of bone marrow and gastrointestinal mucosa. The resulting myelosuppression and mucositis are often prevented (termed methotrexate "rescue") by using folinic acid supplements (not to be confused with folic acid).

Mode of action

Methotrexate inhibits dihydrofolate reductase, an enzyme that is part of the folate synthesis metabolic pathway. Dihydrofolate reductase catalyses the conversion of dihydrofolate to the active tetrahydrofolate. Folic acid is needed for the de novo synthesis of the nucleoside thymidine, required for DNA synthesis). Methotrexate, therefore, inhibits the synthesis of DNA, RNA, thymidylates, and proteins. Methotrexate is cell cycle S-phase selective, and has a greater negative effect on rapidly dividing cells (such as malignant and myeloid cells), which are replicating their DNA, and thus inhibits the growth and proliferation of these cells.

External links

 

<< PreviousWord BrowserNext >>
cities of malaysia
255 (number)
turkmenbashi
ruhnama
space patrol (old time radio show)
ideal home exhibition
smt
settling
tribadism
kara tur
michel chamillart
hydrothermal circulation
scramble for africa
croix de feu
princess patricia of connaught
antiquity
baghdad battery
darby and joan
princess alexandra, duchess of fife
european comic
stream capture
philippe vandevelde
jean richard geurts
tome
demetrius
the scramble for africa
calypsonian
ashdod
dissident
separatism
arne beurling
truncated icosidodecahedron
consortium
institute
american juniors
vanity fair magazine
deep impact (movie)
flag of brazil
thomas abbt
life critical system
abdallah ibn al aftas
abdallah ibn mohammed
haslev
bastion